SCHEMBL3270146

SCHEMBL3270146

N#Cc1ccc(-c2c[c]cc(-c3n[nH]c(=O)o3)c2)cc1

nearest known ligand 0.74

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 20/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18394315 0.85 NOTUM (1.00) NOTUM
SCHEMBL4392841 0.74 NOTUM (0.68) NOTUM
SCHEMBL31141681 0.69 NOTUM (0.63) NOTUM
SCHEMBL1500607 0.69 NOTUM (0.64) NOTUM
SCHEMBL1500521 0.68 NOTUM (0.67) NOTUM
SCHEMBL5542943 0.68 NOTUM (0.92) NOTUM
SCHEMBL31141703 0.66 NOTUM (0.57) NOTUM
SCHEMBL2186256 0.66 MMP3 (0.47)
SCHEMBL5541925 0.65 NOTUM (1.00) NOTUM
SCHEMBL2184380 0.65 KIF11 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010030722-A1 GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE MERCK SHARP & DOHME CORP. (US) 2010-03-18 WO disclosed